Oral anticoagulation therapy in children

Thrombosis Research

Volumn 118, Issue 1, 2006, Pages 85-94

  Bonduel, Mariana M ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Acenocoumarol; Children; Oral anticoagulants; Phenprocoumon; Thrombosis; Warfarin

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN DERIVATIVE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; REVIPARIN; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARGENTINA; BLEEDING; BLINDNESS; CALCIFYING CHONDRODYSTROPHY; CANADA; CHONDRODYSPLASIA PUNCTATA; DATA ANALYSIS; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG SAFETY; ENDOVASCULAR SURGERY; FONTAN PROCEDURE; FRONTAL BOSSING; HAIR LOSS; HEART VALVE PROSTHESIS; HUMAN; HYPOPLASIA; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; OSTEOPOROSIS; PLASMA PROTEIN BINDING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; REVIEW; SKIN NECROSIS; STENT; TERATOGENICITY; THROMBOEMBOLISM; TRACHEA CALCIFICATION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VITAMIN METABOLISM; CHILD; INFANT; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; THROMBOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; PRACTICE GUIDELINES; THROMBOSIS;

EID: 33747598471     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.12.017     Document Type: Review

References (68)

1. Andrew M., Monagle P.T., and Brooker L. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. In: Andrew M., Monagle P.T., and Brooker L. (Eds) (2000), Decker Inc., BC Hamilton, London 5-46
2. Andrew M., David M., Adams M., Ali K., Anderson R., Barnard D., et al. Venous thromboembolic complications (VTE) in children: first analysis of the Canadian Registry of VTE. Blood 83 (1994) 1251-1257
3. Nuss R., Hays T., and Manco-Johnson M. Childhood thrombosis. Pediatrics 96 (1995) 291-294
4. Bonduel M., Hepner M., Sciuccati G., Feliú Torres A., Pieroni G., and Frontroth J.P. Prothrombotic abnormalities in children with venous thromboembolism. J. Pediatr. Hematol./Oncol. 22 (2000) 66-72
5. Andrew M., Monagle P.T., and Brooker L. Epidemiology of venous thromboembolic events. In: Andrew M., Monagle P.T., and Brooker L. (Eds). Thromboembolic complications during infancy and childhood (2000), Decker Inc., BC Hamilton, London 111-146
6. Nowak-Göttl U., Kosch A., and Schlegel N. Thromboembolism in newborns, infants and children. Thromb. Haemost. 86 (2001) 464-475
7. Monagle P., Adams M., Mahoney M., Ali K., Barnard D., Bernstein M., et al. Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry. Pediatr. Res. 47 (2000) 763-766
8. Nowak-Göttl U., Gunther G., Kurnik K., Strater R., and Kirkham F. Arterial ischemic stroke in neonates, infants and children: an overview of underlying conditions, imaging methods, and treatment modalities. Semin. Thromb. Hemost. 29 (2003) 405-414
9. Bonduel M., Sciuccati G., Hepner M., Pieroni G., Feliú Torres A., Frontroth J., et al. Venous thromboembolism (VTE) in children: a prospective ten-year registry in Argentina [abstract]. J. Thromb. Haemost. (2003) 1464 [Suppl.]
10. Bonduel M., Sciuccati G., Hepner M., Torres A.F., Pieroni G., and Frontroth J.P. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch. Neurol. 56 (1999) 967-971
11. Monagle P., Michelson A.D., Bovill E., and Andrew M. Antithrombotic therapy in children. Chest 119 (2001) 344S-370S
12. Hirsh J., Dalen J.E., Anderson D.R., Poller L., Bussey H., Ansell J., et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119 (2001) 8S-21S
13. Andrew M., Marzinotto V., Brooker L.A., Adams M., Ginsberg J., Freedom R., et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb. Haemost. 71 (1994) 265-269
14. Streif W., Andrew M., Marzinotto V., Massicotte P., Chan A.K.C., Julian J.A., et al. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 94 (1999) 3007-3014
15. Andrew M., Monagle P.T., and Brooker L. Oral anticoagulation therapy in pediatric patients. In: Andrew M., Monagle P.T., and Brooker L. (Eds). Thromboembolic complications during infancy and childhood (2000), Decker Inc, BC Hamilton, London 321-325
16. Bonduel M., Sciuccati G., Hepner M., Feliú Torres A., Pieroni G., Frontroth J.P., et al. Acenocoumarol therapy in pediatric patients. J. Thromb. Haemost. 1 (2003) 1740-1743
17. Carpentieri U., Nghiem Q.X., and Harris L.C. Clinical experience with an oral anticoagulant in children. Arch. Dis. Child. 51 (1976) 445-448
18. Doyle J.J., Koren G., Cheng M.Y., and Blanchette V.S. Anticoagulation with sodium warfarin in children: effect of a loading regimen. J. Pediatr. 113 (1988) 1095-1097
19. Evans D.I.K., Rowlands M., and Poller L. Survey of oral anticoagulant treatment in children. J. Clin. Pathol. 45 (1992) 707-708
20. Woods A., Vargas J., Berri G., Kreutzer G., Meschengieser S., and Lazzari M.A. Antithrombotic therapy in children and adolescents. Thromb. Res. 42 (1986) 289-301 [Suppl.]
21. Pattacini C., Manotti C., Pini M., Quintavalla R., and Dettori A.G. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol). Thromb. Haemost. 71 (1994) 188-191
22. Palareti G., Leali N., Coccheri S., Poggi M., Manotti C., D'Angelo A., et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study [ISCOAT]. Lancet 348 (1996) 423-428
23. Aiman A., Rodriguez J.N., Muñiz R., Dieguez J.C., Moreno M.V., Quesada J.A., et al. Estudio comparativo de la estabilidad del tratamiento anticoagulante oral [warfarina versus acenocumarol]. Sangre 41 (1996) 9-11
24. Barcellona D., Vannini M.L., Fenu L., Balestrieri C., and Marongiul F. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?. Thromb. Haemost. 80 (1998) 899-902
25. Casais P., Luceros A.S., Meschengieser S., Bermejo E., and Lazzari M.A. INR variability in anticoagulation with acenocoumarol: is it useful for identifying patients at risk of bleeding and thrombosis?. Haematological 84 (1999) 753-754
26. Veiga F., Escriba A., Maluenda M.P., Lopez Rubio M., Margalet I., Lezana A., et al. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial. Thromb. Haemost. 84 (2000) 559-564
27. Piquet P., Losay J., and Doubine S. Acenocoumarol [Sintrom®] and fluindione [Previscan®] in pediatrics after cardiac surgery. Arch. Pediatr. 9 (2002) 1137-1144
28. Gadisseur A.P.A., van del Meer F.J.M., Adriaansen H.J., Fihn S.D., and Rosendaal F.R. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br. J. Haematol. 117 (2002) 940-946
29. Vermeer C. gg-Carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem. J. 266 (1990) 625-636
30. Ferland G. The vitamin K-dependent proteins: an update. Nutr. Rev. 56 (1998) 223-230
31. Crespi C.L., and Miller V.P. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH: cytochrome P450 oxidoreductase. Pharmacogenetics 7 (1997) 203-210
32. Takanashi K., Tainaka H., Kobayashi K., Yasumori T., Hosakawa M., and Chiba K. CYP2C9 Ile359 and Leu 359 variants: enzyme kinetic study with seven substrates. Pharmacogenetics 10 (2000) 95-104
33. Margaglione M., Colaizzo D., D'Andrea G., Brancaccio V., Ciampa A., Grandone E., et al. Genetic modulation of oral anticoagulation with warfarin. Thromb. Haemos. 84 (2000) 775-778
34. Thijssen H.H.W., and Ritzen B. Acenocoumarol pharmacokinetics in relation to cytochrome P450 2C9 genotype. Clin. Pharmacol. Ther. 74 (2003) 61
35. Haustein K.O. Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocumon. Semin. Thromb. Hemost. 25 (1999) 5-11
36. Massicote P., Leaker M., Marzinotto V., Adams M., Freedom R., Williams W., et al. Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thromb. Haemost. 80 (1998) 570-574
37. Kuhn T.A., Garnett W.R., Wells B.K., and Karnes H.T. Recovery of warfarin from an enteral nutrient formula. Am. J. Hosp. Pharm. 46 (1989) 1395-1399
38. Biron C., Licznar P., Hansel S., and Schved J.F. Oral anticoagulant drugs: do not cut tablets in quarters. Thromb. Haemost. 82 (1999) 1201
39. Marzinotto V., Monagle P., Chan A., Massicotte P., Leaker M., and Andrew M. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinic and the home setting. Pediatr. Cardiol. 21 (2000) 347-352
40. Nowatzke W.L., Landt M., Smith C., Wilhite T., Canter C., and Luchtman-Jones L. Whole blood international normalization ratio measurements in children using near-patient monitors. J. Pediatr. Hematol. Oncol. 25 (2003) 33-37
41. Massicotte P., Julian J.A., Gent M., Shields K., Marzinotto V., Szechtman B., et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb. Res. 109 (2003) 85-92
42. Ridker P.M., Goldhaber S.Z., Danielson E., Rosenberg Y., Eby C.S., Deitcher S.R., et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N. Engl. J. Med. 348 (2003) 1425-1434
43. Solymar L., Rao P.S., Mardini M.K., Fawzy M.E., and Guinn G. Prosthetic valves in children and adolescents. Am. Heart J. 121 (1991) 557-568
44. Bradley L.M., Midgley F.M., Watson D.C., Getson P.R., and Scott III L.P. Anticoagulation therapy in children with mechanical prosthetic cardiac valves. Am. J. Cardiol. 56 (1985) 533-535
45. Borkon A.M., Soule L., Reitz B.A., Gott V.L., and Gardner T.J. Five-year follow-up after valve replacement with the St. Jude Medical valve in infants and children. Circulation 74 (1986) 110-115
46. El Makhlouf A., Friedli B., Oberhansli I., Rouge J.C., and Faidutti B. Prosthetic heart valve replacement in children. J. Thorac. Cardiovasc. Surg. 93 (1987) 80-85
47. Human D.G., Joffe H.S., Fraser C.B., and Barnard C.N. Mitral valve replacement in children. J. Thorac. Cardiovasc. Surg. 83 (1982) 873-877
48. Milano A., Vouhe P.R., Baillot-Vernant F., Donzeau-Gouge P., Trinquet F., Roux P.M., et al. Late results after left-sided cardiac valve replacement in children. J. Thorac. Cardiovasc. Surg. 92 (1986) 218-225
49. Stewart S., Cianciotta D., Alexson C., and Manning J. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valves. J. Thorac. Cardiovasc. Surg. 93 (1987) 551-554
50. Schaffer M.S., Clarke D.R., Campbell D.N., Madigan C.K., Wiggins Jr. J.W., and Wolfe R.R. The St. Jude Medical cardiac valve and children: role of anticoagulant therapy. J. Am. Coll. Cardiol. 9 (1987) 235-239
51. Antunes M.J., Vanderdonck K.M., and Sussman M.J. Mechanical valve replacement in children and teenagers. Eur. J. Cardio-thorac. Surg. 3 (1989) 222-228
52. Champsaur G., Robin J., Trone F., Curtil A., Ninet J., Sassolas F., et al. Mechanical valve in aortic position is a valid option in children and adolescents. Eur. J. Cardio-thorac. Surg. 11 (1997) 117-122
53. Monagle P. Thrombosis in pediatric cardiac patients. Semin. Thromb. Hemost. 29 (2003) 547-556
54. Jahangiri M., Ross D.B., Redington A.N., Lincoln C., and Shinebourne E.A. Thromboembolism after the Fontan procedure and its modifications. Ann. Thorac. Surg. 58 (1994) 1409-1414
55. Rosenthal D., Friedman A., Kleinman S., Kopf G., Rosenfeld L., and Hellenbrand W. Thromboembolic complications after Fontan operations. Circulation 92 (1995) II 287-II 293 [suppl.]
56. Fyfe D.A., Kline C.H., Sade R.M., and Gillette P.C. Transesophageal echocardiography detects thrombus formation not identified by transthoracic echocardiography after the Fontan operation. J. Am. Coll. Cardiol. 18 (1991) 1733-1737
57. Shirai L.K., Rosenthal D.N., Reitz B.A., Robbins R.C., and Dubin A.M. Arrhythmias and thromboembolic complications after the extra cardiac Fontan operation. J. Thorac. Cardiovasc. Surg. 115 (1998) 499-505
58. Monagle P., Cochrane A., McCrindle B., Benson L., Williams W., and Andrew M. Editorial: thromboembolic complications after Fontan procedures-The role of prophylactic anticoagulation. J. Thorac. Cardiovasc. Surg. 115 (1998) 493-498
59. Jacobs M.L., Pourmoghadam K.K., Geary E.M., Reyes A.T., Madan N., McGrath L.B., et al. Fontan's operation: is aspirin enough? Is coumadin too much?. Ann. Thorac. Surg. 73 (2002) 64-68
60. Newall F., Barnes C., Savoia H., Campbell J., and Monagle P. Warfarin therarpy in children who require long-term total parenteral nutrition. Pediatrics 12 (2003) 386-388
61. Nowak-Göttl U., Straeter R., Sebire G., and Kirkham F. Antithrombotic drug treatment of pediatric patients with ischemic stroke. Paediatr. Drugs 5 (2003) 167-175
62. deVeber G., Chan A., Monagle P., Marzinotto V., Armstrong D., Massicotte P., et al. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch. Neurol. 55 (1998) 1533-1537
63. Bonduel M., Sciuccati G., Hepner M., Pieroni G., Feliú Torres A., Frontroth J., et al. Cerebral sinovenous thrombosis [SVT] in children: a prospective ten-year registry in Argentina [abstract]. J. Thromb. Haemost. (2003) 1003 [Suppl.]
64. Cheung A.M., Halton J., Dinyari M., Chan A., Shaughnessy S., Webber C., et al. Bone mineral density (BMD) in a cohort of children on long term warfarin therapy (>1 year) (abstract). J. Thromb. Haemost. (2001) 1729 [Suppl.]
65. Hooshang T., and Capitanio M. Tracheobronchial calcification: an observation in three children after mitral valve replacement and warfarin sodium therapy. Radiology 176 (1990) 728-730
66. Gatti L., Carnelli V., Rusconi R., and Moia M. Heparin-induced thrombocytopenia and warfarin-induced skin necrosis in a child with severe protein C deficiency: successful treatment with dermatan sulfate and protein C concentrate. J. Thromb. Haemost. 2 (2003) 387-388
67. Bony C., Zyka F., Tiran-Rajaofera I., Attali T., De Napoli S., and Alessandri J.L. Warfarin fetopathy. Arch. Pediatr. 9 (2002) 705-708
68. Bolton-Maggs P., and Brook L. The use of vitamin K for reversal of over-warfarinization in children. Br. J. Haematol. 118 (2002) 922-928